Advertisement

Ads Placeholder
Loading...

Syntara Limited

SNT.AXASX
Healthcare
Drug Manufacturers - Specialty & Generic
$0.03
$-0.00(-3.13%)
Australian Market opens in 61h 24m

Syntara Limited Fundamental Analysis

Syntara Limited (SNT.AX) shows weak financial fundamentals with a PE ratio of -5.75, profit margin of 0.00%, and ROE of -61.92%. The company generates N/A in annual revenue with N/A year-over-year growth of N/A.

Key Strengths

Cash Position33.10%
PEG Ratio-0.06
Current Ratio3.93

Areas of Concern

ROE-61.92%
Operating Margin0.00%
We analyze SNT.AX's fundamental strength across five key dimensions.

The stock receives a Fundamental Health Score of -40.0/100 based on profitability, valuation, growth, and balance sheet metrics. The F grade reflects weak fundamentals and significant financial concerns.

Fundamental Health Score

F
-40.0/100

We analyze SNT.AX's fundamental strength across five key dimensions:

Efficiency Score

Weak

SNT.AX struggles to generate sufficient returns from assets.

ROA > 10%
-36.93%

Valuation Score

Excellent

SNT.AX trades at attractive valuation levels.

PE < 25
-5.75
PEG Ratio < 2
-0.06

Growth Score

Weak

SNT.AX faces weak or negative growth trends.

Revenue Growth > 5%
N/A
EPS Growth > 10%
N/A

Financial Health Score

Excellent

SNT.AX maintains a strong and stable balance sheet.

Debt/Equity < 1
0.01
Current Ratio > 1
3.93

Profitability Score

Weak

SNT.AX struggles to sustain strong margins.

ROE > 15%
-6192.28%
Net Margin ≥ 15%
0.00%
Positive Free Cash Flow
No

Key Financial Metrics

Is SNT.AX Expensive or Cheap?

P/E Ratio

SNT.AX trades at -5.75 times earnings. This suggests potential undervaluation.

-5.75

PEG Ratio

When adjusting for growth, SNT.AX's PEG of -0.06 indicates potential undervaluation.

-0.06

Price to Book

The market values Syntara Limited at 2.84 times its book value. This may indicate undervaluation.

2.84

EV/EBITDA

Enterprise value stands at -5.47 times EBITDA. This is generally considered low.

-5.47

How Well Does SNT.AX Make Money?

Net Profit Margin

For every $100 in sales, Syntara Limited keeps $0.00 as profit after all expenses.

0.00%

Operating Margin

Core operations generate 0.00 in profit for every $100 in revenue, before interest and taxes.

0.00%

ROE

Management delivers $-61.92 in profit for every $100 of shareholder equity.

-61.92%

ROA

Syntara Limited generates $-36.93 in profit for every $100 in assets, demonstrating efficient asset deployment.

-36.93%

Following the Money - Real Cash Generation

FCF Per Share

Each share generates $-0.01 in free cash annually.

$-0.01

FCF Yield

SNT.AX converts -21.94% of its market value into free cash.

-21.94%

Financial Ratios Analysis

Valuation Ratios

P/E Ratio

Price to earnings ratio

-5.75

vs 25 benchmark

PEG Ratio

Price/earnings to growth ratio

-0.06

vs 25 benchmark

P/B Ratio

Price to book value ratio

2.84

vs 25 benchmark

P/S Ratio

Price to sales ratio

0.00

vs 25 benchmark

Financial Health

Debt/Equity

Total debt to shareholders' equity

0.005

vs 25 benchmark

Current Ratio

Current assets to current liabilities

3.93

vs 25 benchmark

Efficiency Ratios

ROE

Return on equity percentage

-0.62

vs 25 benchmark

ROA

Return on assets percentage

-0.37

vs 25 benchmark

ROCE

Return on capital employed

0.00

vs 25 benchmark

How SNT.AX Stacks Against Its Sector Peers

MetricSNT.AX ValueSector AveragePerformance
P/E Ratio-5.7528.54 Better (Cheaper)
ROE-61.92%738.00% Weak
Net Margin0.00%-43982.00% (disorted) Weak
Debt/Equity0.010.34 Strong (Low Leverage)
Current Ratio3.932806.01 Strong Liquidity
ROA-36.93%-14624.00% (disorted) Weak

SNT.AX outperforms its industry in 3 out of 6 key metrics, but lagging in ROE.

Historical Growth Performance

5-Year Growth Trajectory

This section reviews Syntara Limited's 5-year compound annual growth rate (CAGR) and compares its performance against the typical investment style of its industry.

Revenue CAGR

N/A

Industry Style: Defensive, Growth, Innovation

EPS CAGR

N/A

Industry Style: Defensive, Growth, Innovation

FCF CAGR

N/A

Industry Style: Defensive, Growth, Innovation

Fundamental Analysis FAQ